Efficacy of guided autofluorescence laser therapy in MRONJ: a systematic review

Eur Rev Med Pharmacol Sci. 2023 Dec;27(24):11817-11831. doi: 10.26355/eurrev_202312_34780.

Abstract

Objective: This review aims to explore the efficacy of fluorescence-guided excision in the treatment of necrotic bone and highlights the importance of fluorescence in distinguishing viable margins from necrotic ones for a more targeted and predictable management of MRONJ.

Materials and methods: The review was conducted according to PRISMA guidelines using PubMed, Scopus, and Web of Science databases from January 1, 2008, to May 17, 2023. The Boolean search strategy with the following keywords "osteonecrosis" AND "fluorescence" was performed. Then, the articles were subjected to screening and eligibility phases. The papers about the use of autofluorescence-guided laser therapy in patients with jaw osteonecrosis were included.

Results: A total of 320 articles were initially identified through an electronic search, and ultimately, 17 papers were included in the qualitative analysis.

Conclusions: In conclusion, our findings demonstrate that the VELscope system allows for clear visualization of the bone, making guided autofluorescence a precise, safe, and reliable technique.

Publication types

  • Systematic Review

MeSH terms

  • Bisphosphonate-Associated Osteonecrosis of the Jaw* / therapy
  • Bone Density Conservation Agents* / adverse effects
  • Diphosphonates / adverse effects
  • Humans
  • Laser Therapy*
  • Low-Level Light Therapy

Substances

  • Bone Density Conservation Agents
  • Diphosphonates